Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.
2.

PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.

Tiacci E, Pileri S, Orleth A, Pacini R, Tabarrini A, Frenguelli F, Liso A, Diverio D, Lo-Coco F, Falini B.

Cancer Res. 2004 Oct 15;64(20):7399-404.

3.

Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.

Chu PG, Loera S, Huang Q, Weiss LM.

Am J Clin Pathol. 2006 Oct;126(4):534-44.

PMID:
16938666
4.

Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.

Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A.

Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):96-101. doi: 10.1097/PAI.0b013e3181845ef4.

PMID:
18838917
6.

Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).

Valbuena JR, Medeiros LJ, Rassidakis GZ, Hao S, Wu CD, Chen L, Lin P.

Am J Clin Pathol. 2006 Aug;126(2):235-40.

PMID:
16891199
7.

Lymphoblastic lymphoma.

Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.

Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26. Review.

PMID:
21273093
8.

Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.

Simmons S, Knoll M, Drewell C, Wolf I, Mollenkopf HJ, Bouquet C, Melchers F.

Blood. 2012 Nov 1;120(18):3688-98. doi: 10.1182/blood-2012-03-414821. Epub 2012 Aug 27.

10.

B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).

Johnson RC, Ma L, Cherry AM, Arber DA, George TI.

Am J Clin Pathol. 2013 Sep;140(3):355-62. doi: 10.1309/AJCPFBCFXP94AKWJ.

PMID:
23955454
11.

Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.

Nishii K, Kita K, Miwa H, Shikami M, Taniguchi M, Usui E, Katayama N, Shiku H.

Int J Hematol. 2000 Jun;71(4):372-8.

PMID:
10905058
12.

The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.

Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J.

Am J Surg Pathol. 2002 Oct;26(10):1343-50.

PMID:
12360049
13.

[Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].

Chen DB, Wang Y, Song QJ, Shen DH.

Zhonghua Bing Li Xue Za Zhi. 2012 Jun;41(6):376-81. doi: 10.3760/cma.j.issn.0529-5807.2012.06.004. Chinese.

PMID:
22932404
14.

B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.

Imoto N, Hayakawa F, Kurahashi S, Morishita T, Kojima Y, Yasuda T, Sugimoto K, Tsuzuki S, Naoe T, Kiyoi H.

J Biol Chem. 2016 Feb 26;291(9):4723-31. doi: 10.1074/jbc.M115.637835. Epub 2015 Dec 24.

16.

Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.

García-Cosío M, Santón A, Martín P, Camarasa N, Montalbán C, García JF, Bellas C.

Mod Pathol. 2004 Dec;17(12):1531-8.

17.

Highly aggressive lymphomas in adults.

Sweetenham JW.

Hematol Oncol Clin North Am. 2008 Oct;22(5):965-78, ix. doi: 10.1016/j.hoc.2008.07.009. Review.

PMID:
18954746
18.

PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.

Shang Z, Zhao Y, Zhou K, Xu Y, Huang W.

Int J Hematol. 2013 May;97(5):599-603. doi: 10.1007/s12185-013-1309-9. Epub 2013 Mar 26.

PMID:
23529845
19.

Expression of PAX5 splice variants: a phenomenon of stress-induced, illegitimate splicing?

Nebral K, Krehan D, Strehl S.

Br J Haematol. 2011 Oct;155(2):277-80. doi: 10.1111/j.1365-2141.2011.08677.x. Epub 2011 Apr 11. No abstract available.

PMID:
21480862
20.

Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.

Al-Shieban S, Byrne E, Trivedi P, Morilla R, Matutes E, Naresh KN.

Br J Haematol. 2011 Aug;154(4):466-70. doi: 10.1111/j.1365-2141.2011.08760.x. Epub 2011 Jul 2.

PMID:
21722099

Supplemental Content

Support Center